ECOG-ACRIN Cancer Research Group

Dr. Peter O'Dwyer, our ECOG-ACRIN group co-chair and co-author of a new Friends' white paper on pragmatic trial designs, is in Washington, DC, today, attending the Friends’ Annual Meeting 2024. Join us live at the link below to hear the discussion! See below for a link to the white paper. Other topics today: enhancing interim overall survival analyses accuracy and reliability, and advancing ctDNA as an intermediate endpoint in oncology drug development. Meeting link: https://lnkd.in/erimYnVd White paper link: chrome-extension://efaidnbmnnnibpcajpcglclefindmkaj/https://lnkd.in/emdGdYH2 #FriendsAM24

The #myeloMATCH portfolio of precision medicine trials in #myeloid cancers is now open at 150 treatment sites across the US and Canada and growing. "Over the last several years, investigators from the National Cancer Institute and the North American cooperative groups have been working to design a platform that will allow for state-of-the-art precision medicine diagnostics and treatment. The opening of these myeloMATCH trials heralds a new era in treating myeloid malignancies," said?Selina M. Luger, MD, FRCPC,?of the University of Pennsylvania's Abramson Cancer Center. Dr. Luger chairs the ECOG-ACRIN Leukemia Committee. To learn more, read the press release. https://lnkd.in/g7ZdfCSX

Exciting to see that this new #RealWorldData registry study for patients with EGFR-positive non-small cell #LungCancer is active!

Leaders of the #Cancer Cooperative Groups propose significant changes to #correlativescience to expand resources and remove substantial barriers. Read more on their recommendations for public-private partnerships and major process innovations here:?https://lnkd.in/eF7i8b5Y.

Chemotherapy before surgery helps patients with nose and sinus #cancer avoid debilitating eye and bone removal. Striking #clinicaltrial results at #ESMO24. #CancerSurgery @DrNabilSaba @WinshipAtEmory Barbara Burtness @YaleCancer @NCI_CTEP https://lnkd.in/efHGnCW7

Striking #clinicaltrial results to be presented at #ESMO24 https://lnkd.in/efHGnCW7 #CancerSurgery #Science #News #Media #Medicine #Europe #patientcare #healthcare #MedComms #Breaking #Oncology #Cancer @DrNabilSaba @WinshipAtEmory Barbara Burtness @YaleCancer @NCI_CTEP

There is still time to submit a research abstract for early-career investigators interested in presenting your research as part of the upcoming Fall 2024 Group Meeting. The submission deadline is tomorrow, Thursday, September 12 at 11:59 PM (Eastern Time). More here: https://lnkd.in/eXJSAGFM

There is one week left to submit an abstract for the 2024 Young Investigator Symposium! ?? The Symposium is an opportunity for early-career researchers to share their work, connect w/ experienced investigators, & learn about potential research opportunities. https://lnkd.in/eXJSAGFM

Patients have a lot on their plates. Among the priorities of the Biden Administration’s ambitious Cancer Moonshot initiative is to increase access to individuals in hospitals and cancer centers to help guide patients through the healthcare system. Read more about these services, which have been shown to improve the patient experience and treatment outcomes by helping patients and caregivers manage the many challenges of a cancer diagnosis. Navigation can also help to advance another national goal: including more patients in clinical trials. #patientcare #patientnavigation #patientnavigator #cancermoonshot #clinicaltrials #medicalresearch https://lnkd.in/eN5vPDNc

ICYMI: Submit an Abstract for the 2024 Young Investigator Symposium! ?? The Symposium is an opportunity for early-career #researchers to share their work, connect with experienced #investigators, and learn about potential research #opportunities. More here: https://lnkd.in/eXJSAGFM